Kristian Reich, Chief Scientific Officer at MoonLake Immunotherapeutics (MLTX), sold 275,816 shares at $15.08 ($4.1M) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Open-market sale of $4.1M MLTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.08 | 130,000 | $2.0M | 48.2% |
| 2 | $14.43 | 72,908 | $1.1M | 25.9% |
| 3 | $14.43 | 72,908 | $1.1M | 25.9% |
| Total | $14.74 avg | 275,816 | $4.1M | 100% |
| Filing → |
| MLTX | SELL | 2026-07-21 | $878K | — | Filing → |
| MLTX | SELL | 2026-07-20 | $322K | — | Filing → |
| MLTX | SELL | 2026-06-17 | $2.9M | — | Filing → |